Cointime

Novel Bioventures

investment firm

About

Novel Bioventures is a venture capital fund focused on early stage investments.

Highlights

Investments
4
Lead Investments
1
Exits
3

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
4
1
Novel Bioventures has made 4 investments. Their most recent investment was on May 11, 2005, when Cellerant Therapeutics raised $16M.
Date Company Name
Round Money Raised Industry Lead Investor
May 11, 2005 Cellerant Therapeutics
Series B $16M Biotechnology Yes
Jan 27, 2005 Predix Pharmaceuticals
Series C $43M Health Care —
Jun 1, 2004 ARYx Therapeutics
Series D $55M Biotechnology —
Jan 27, 2004 TransMedics
Series B $27.60M Health Care —

Exits

Novel Bioventures has had 3 exits. Novel Bioventures most notable exits include TransMedics ,   ARYx Therapeutics

Date Company Name Exit Type Industry
May 1, 2019 TransMedics IPO Health Care Detail
Nov 7, 2007 ARYx Therapeutics IPO Biotechnology Detail
Oct 26, 2005 Predix Pharmaceuticals M&A Health Care Detail
Cointime
Содержание
компания